
Covalon Investor Relations Material
Latest events

Status Update
Covalon
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
Covalon Technologies Ltd is a medical device company focused on the research, development, manufacture, commercialization and licensing of medical technologies and products for the treatment of chronic wounds and infected wounds. The Company has 3 proprietary platforms that include a Collagen Matrix Platform used to manufacture a series of products to treat chronic and infected wounds. The second platform is Antimicrobial Silicone Adhesive Platform used to manufacture pre- and post-surgical products with antimicrobial properties that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad spectrum antimicrobial activity.
Key slides for Covalon Technologies Ltd


Q4 2022
Covalon Technologies Ltd


Q2 2023
Covalon Technologies Ltd
Latest articles

Marvel-ous Reporting: Marvel’s Comic Inspired Reports
Shareholder reports are often considered tedious and dry. However, in the late 1980s and early 1990s, Marvel Comics revolutionized this perception by transforming its financial reports into captivating comic books.
8 Dec 2023

The Payments Value Chain: A Complex Ecosystem
The payments industry is a complex and dynamic field involving multiple key players. These include customers, merchants, issuers, acquirers, card networks, and various other entities together forming the payments value chain.
8 Dec 2023

NIBE: Creating Millionaires and a Greener Future
NIBE, just like IKEA, was founded in a rural part of Sweden called Småland. The company offers a wide range of pumps, wood stoves, and solar panels.
6 Dec 2023
Ticker symbol
COV
Country
🇨🇦 Canada